BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di-Wen S, Pan GZ, Hao L, Zhang J, Xue QZ, Wang P, Yuan QZ. Improved antitumor activity of epirubicin-loaded CXCR4-targeted polymeric nanoparticles in liver cancers. Int J Pharm 2016;500:54-61. [PMID: 26748365 DOI: 10.1016/j.ijpharm.2015.12.066] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Yang T, Du G, Cui Y, Yu R, Hua C, Tian W, Zhang Y. pH-sensitive doxorubicin-loaded polymeric nanocomplex based on β-cyclodextrin for liver cancer-targeted therapy. Int J Nanomedicine 2019;14:1997-2010. [PMID: 30962684 DOI: 10.2147/IJN.S193170] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Ghalehkhondabi V, Soleymani M, Fazlali A. Folate-targeted nanomicelles containing silibinin as an active drug delivery system for liver cancer therapy. Journal of Drug Delivery Science and Technology 2021;61:102157. [DOI: 10.1016/j.jddst.2020.102157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
3 Ding J, Chen G, Chen G, Guo M. One-Pot Synthesis of Epirubicin-Capped Silver Nanoparticles and Their Anticancer Activity against Hep G2 Cells. Pharmaceutics 2019;11:E123. [PMID: 30884757 DOI: 10.3390/pharmaceutics11030123] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
4 Zheng N, Liu W, Li B, Nie H, Liu J, Cheng Y, Wang J, Dong H, Jia L. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib. J Exp Clin Cancer Res 2019;38:232. [PMID: 31151472 DOI: 10.1186/s13046-019-1216-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
5 Biswaro LS, da Costa Sousa MG, Rezende TMB, Dias SC, Franco OL. Antimicrobial Peptides and Nanotechnology, Recent Advances and Challenges. Front Microbiol 2018;9:855. [PMID: 29867793 DOI: 10.3389/fmicb.2018.00855] [Cited by in Crossref: 83] [Cited by in F6Publishing: 64] [Article Influence: 20.8] [Reference Citation Analysis]
6 Davarnejad R, Layeghy K, Soleymani M, Ayazi A. Encapsulation of Quercetin in a Mixed Nanomicellar System to Enhance its Cytotoxicity against Breast Cancer Cells. Chem Eng & Technol 2022;45:1100-5. [DOI: 10.1002/ceat.202200025] [Reference Citation Analysis]
7 Zhou S, Zhang T, Peng B, Luo X, Liu X, Hu L, Liu Y, Di D, Song Y, Deng Y. Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity. Int J Pharm 2017;523:203-16. [PMID: 28336455 DOI: 10.1016/j.ijpharm.2017.03.034] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 8.8] [Reference Citation Analysis]
8 Du G, Wang S, Yuan H, Wang J, Song Y, Liu T, Tian W. Size‐Stable Supramolecular Hyperbranched Polymer Vesicles for Redox‐Triggered Double‐Drug Release. Macromol Chem Phys 2019;220:1800467. [DOI: 10.1002/macp.201800467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Chowdhury A, Kunjiappan S, Panneerselvam T, Somasundaram B, Bhattacharjee C. Nanotechnology and nanocarrier-based approaches on treatment of degenerative diseases. Int Nano Lett 2017;7:91-122. [DOI: 10.1007/s40089-017-0208-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 32] [Article Influence: 13.4] [Reference Citation Analysis]
10 Rahdar A, Hajinezhad MR, Barani M, Sargazi S, Zaboli M, Ghazy E, Baino F, Cucchiarini M, Bilal M, Pandey S. Pluronic F127/Doxorubicin microemulsions: Preparation, characterization, and toxicity evaluations. Journal of Molecular Liquids 2022;345:117028. [DOI: 10.1016/j.molliq.2021.117028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
11 Riccardi C, Musumeci D, Irace C, Paduano L, Montesarchio D. Ru III Complexes for Anticancer Therapy: The Importance of Being Nucleolipidic: Ru III Complexes for Anticancer Therapy: The Importance of Being Nucleolipidic. Eur J Org Chem 2017;2017:1100-19. [DOI: 10.1002/ejoc.201600943] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
12 Usmani A, Mishra A, Ahmad M. Nanomedicines: a theranostic approach for hepatocellular carcinoma. Artificial Cells, Nanomedicine, and Biotechnology 2018;46:680-90. [DOI: 10.1080/21691401.2017.1374282] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
13 Janicka M, Gubernator J. Use of nanotechnology for improved pharmacokinetics and activity of immunogenic cell death inducers used in cancer chemotherapy. Expert Opinion on Drug Delivery 2016;14:1059-75. [DOI: 10.1080/17425247.2017.1266333] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
14 Yazdian-Robati R, Arab A, Ramezani M, Rafatpanah H, Bahreyni A, Nabavinia MS, Abnous K, Taghdisi SM. Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo. Drug Dev Ind Pharm 2019;45:603-10. [PMID: 30633594 DOI: 10.1080/03639045.2019.1569029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
15 Baghdadi NE, Burke BP, Alresheedi T, Nigam S, Saeed A, Almutairi F, Domarkas J, Khan A, Archibald SJ. Multivalency in CXCR4 chemokine receptor targeted iron oxide nanoparticles. Dalton Trans 2021;50:1599-603. [PMID: 33502425 DOI: 10.1039/d0dt02626c] [Reference Citation Analysis]
16 Dutta B, Barick KC, Hassan PA. Recent advances in active targeting of nanomaterials for anticancer drug delivery. Adv Colloid Interface Sci 2021;296:102509. [PMID: 34455211 DOI: 10.1016/j.cis.2021.102509] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
17 Wang N, Liu C, Yao W, Wang X, Zhou H, Chen H, Qiao W. A sequential multistage-targeted nanoparticles for MR imaging and efficient chemo/chemodynamic synergistic therapy of liver cancer. Applied Materials Today 2021;24:101147. [DOI: 10.1016/j.apmt.2021.101147] [Reference Citation Analysis]
18 Tang Z, Ma Q, Chen X, Chen T, Ying Y, Xi X, Wang L, Ma C, Shaw C, Zhou M. Recent Advances and Challenges in Nanodelivery Systems for Antimicrobial Peptides (AMPs). Antibiotics (Basel) 2021;10:990. [PMID: 34439040 DOI: 10.3390/antibiotics10080990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Sudha T, Bharali DJ, Yalcin M, Darwish NH, Debreli Coskun M, Keating KA, Lin HY, Davis PJ, Mousa SA. Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac. Int J Nanomedicine 2017;12:1305-15. [PMID: 28243091 DOI: 10.2147/IJN.S123742] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
20 Casciaro B, Ghirga F, Quaglio D, Mangoni ML. Inorganic Gold and Polymeric Poly(Lactide-co-glycolide) Nanoparticles as Novel Strategies to Ameliorate the Biological Properties of Antimicrobial Peptides. CPPS 2020;21:429-38. [DOI: 10.2174/1389203720666191203101947] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
21 Giráldez-Pérez RM, Grueso E, Domínguez I, Pastor N, Kuliszewska E, Prado-Gotor R, Requena-Domenech F. Biocompatible DNA/5-Fluorouracil-Gemini Surfactant-Functionalized Gold Nanoparticles as Promising Vectors in Lung Cancer Therapy. Pharmaceutics 2021;13:423. [PMID: 33801142 DOI: 10.3390/pharmaceutics13030423] [Reference Citation Analysis]
22 Chiu HI, Samad NA, Fang L, Lim V. Cytotoxicity of targeted PLGA nanoparticles: a systematic review. RSC Adv 2021;11:9433-49. [PMID: 35423427 DOI: 10.1039/d1ra00074h] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
23 Chowdhury MMH, Salazar CJJ, Nurunnabi M. Recent advances in bionanomaterials for liver cancer diagnosis and treatment. Biomater Sci 2021;9:4821-42. [PMID: 34032223 DOI: 10.1039/d1bm00167a] [Reference Citation Analysis]
24 Su T, Yang B, Gao T, Liu T, Li J. Polymer nanoparticle-assisted chemotherapy of pancreatic cancer. Ther Adv Med Oncol 2020;12:1758835920915978. [PMID: 32426046 DOI: 10.1177/1758835920915978] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
25 Farooqi HMU, Khalid MAU, Kim KH, Lee SR, Choi KH. Real-time physiological sensor-based liver-on-chip device for monitoring drug toxicity. J Micromech Microeng 2020;30:115013. [DOI: 10.1088/1361-6439/ababf4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]